Anvil Biosciences

Developer of nucleic acid-based therapeutics for rare autoimmune diseases

placeHayward, California, United States calendar_todayFounded 2012 language anvilbio.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 3 times.

YearFilings
20161
20181

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon